BooksTestimonialsInterviewsLibraryArticlesShop Here 

Gilead’s New One Pill a Day Cure for Hepatitis C

By Lloyd Wright, NHC, Best Selling Author

Over the last 2 ½ years, I have had a handful of clients that were successful at getting into the Gilead Sciences phase 1, 2 and 3 trials for their new drug, Sofosbuvir, for the treatment of Hepatitis C.

Gilead Sofosbuvir At the same time I had numerous clients that were rejected for these same trials. After reviewing lab work sent to me by these people and having lengthy discussions on the phone with them, it appears that the trials were being manipulated. They chose the healthiest people for testing their drug, not just physically healthy but ones with the most positive attitudes. I suspected this all along and then on November 4, 2013, the New York Times published an article on the new drug and they wrote, in reference to the previous 100% cure pushed in 2011 with full page ads in the Los Angeles Times, constant advertising on KNX News radio, that this was a 100% cure, “There was a huge rush to treatment. But doctors now say that side effects were worse than expected, in part because the sickest patients had been excluded from the clinical trials of the drugs.” “A lot of that didn’t come to light until after the drugs were approved,” said Dr. Frain R. Edlin, an associate professor of public health and medicine at Weill Cornell Medical College. “Then it turns out they were just horrible.”.  (1)

This one pill a day drug as it is pushed, is really very misleading. The facts are, as approved by the FDA on December 6, 2013, Sofosbuvir for geno type 2 and geno type 3 is not just one pill a day. It also must be accompanied with Ribavirin, 600 mg in the morning and 600 mg in the evening. Ribavirin is no walk in the park. While not being as horrible as interferon, it does pose serious health problems and even death.

The Mayo Clinic informed me that they conducted many trials on Gilead’s new drug and that most people developed headaches and most of those had to be treated with drugs. Also most people developed low platelets, anemia, low RBC (red blood count) and had to be treated with Procrit and other growth hormones to keep people able to sustain life while on treatment. Nausea, diarrhea, vomiting, itching, rash, insomnia and fever were also common. Fatigue is also overwhelming. People need to have lab work once a week to assure they are not in serious near death condition.

Further, the material handed out by Mayo clinic says, “Before receiving FDA approval, these drugs are tested and studied in many clinical trials. These clinical trials give a lot of information about drugs (such as side effects and potential benefits). However these clinical trials are very controlled and sometimes do not include all types of patients, they cannot always show what happens in the ‘real world’. For example, the clinical trials did not include patients with kidney disease, transplant subjects, HIV infected, etc., and only included a small number of other types of patients (such as African Americans, cirrhotics (advanced scarring of the liver), elderly, etc.)”. (2)

As reported by Forbes, this $1,000.00 per pill, $84,000.00 dollars for just the Gilead pill once a day for 12 weeks, not including the Ribavirin, lab work or doctor visits, actually cost $68.00 to manufacture for the entire 12-week treatment. (3)

If you are one that cannot find their way to pay over $100,000.00 for a treatment that is sure to have some as yet unknown side effects down the road, get a copy of Triumph Over Hepatitis C and Hepatitis C, A Do It Yourself Guide for Health.
Live Long and Prosper!

 

References

1. Hepatitis C, a silent killer, meets its match. NYTimes.com 11/4/13

2. Research Participant consent and privacy authorization form. Mayo Clinic

3. Will the new hepatitis c drugs trigger a battle over cost? Forbes 11/11/2013

--> Back to the top

............................